CVR: 39432714
DeLiver Pharma ApS is a Danish company of the type Anpartsselskab based in Faaborg, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Niels Jonas Heilskov Graversen. The company's owners include MOESTRUP HOLDING 2007 ApS, MØLLER HOLDING 2007 ApS and PHIDEAS ApS. In 2025, the company reported a gross profit of DKK -20,487 and a net result of DKK -31,867 compared with DKK -21,682 the year before. Equity amounted to DKK 163,221.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med medicinsk udvikling samt enhver i forbindelse hermed stående virksomhed.
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
DeLiver Pharma ApS has published its annual report for 2025. Gross profit came to DKK -20,487, and the net result was DKK -31,867.
Address changed to Sanatorievej 8, 5600 Faaborg (May 29, 2026).
Contact info changed: new phone: 21733311, new email: [email protected] (May 29, 2026).
Address changed to Fuglevej 21 21, 8592 Anholt (January 7, 2026).
DeLiver Pharma ApS has published its annual report for 2024. Gross profit came to DKK -10,302, and the net result was DKK -21,682.
DeLiver Pharma ApS has published its annual report for 2023. Gross profit came to DKK 118,663, and the net result was DKK 107,283.
DeLiver Pharma ApS has published its annual report for 2022. Gross profit came to DKK -17,951, and the net result was DKK -29,331.
DeLiver Pharma ApS has published its annual report for 2021. Gross profit came to DKK -21,884, and the net result was DKK -146,911.
DeLiver Pharma ApS has published its annual report for 2020. Gross profit came to DKK -19,597, and the net result was DKK -113,852.
DeLiver Pharma ApS has published its annual report for 2019. Revenue came to DKK 79,000, and the net result was DKK -12,094.
DeLiver Pharma ApS has published its interim report for the period March 9, 2018 – December 31, 2018.
As of March 9, 2018, Jens Kristian Damsgaard has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Niels Jonas Heilskov Graversen has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Søren Kragh Moestrup has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Holger Jon Møller has joined the board of directors of DeLiver Pharma ApS.
As of March 9, 2018, Niels Jonas Heilskov Graversen is registered as director of DeLiver Pharma ApS.
As of March 9, 2018, MOESTRUP HOLDING 2007 ApS is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
As of March 9, 2018, MØLLER HOLDING 2007 ApS is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
As of March 9, 2018, PHIDEAS ApS is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
As of March 9, 2018, SCIENCE VENTURES DENMARK A/S is registered as an owner of DeLiver Pharma ApS with an ownership share of 25%.
DeLiver Pharma ApS was founded on March 9, 2018.
Companies in the same industry and area
companydata.dk